Page last updated: 2024-11-04

temozolomide and Trypanosomiasis, African

temozolomide has been researched along with Trypanosomiasis, African in 1 studies

Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.

Research Excerpts

ExcerptRelevanceReference
" For these reasons, the anti-glioblastoma drug temozolomide was tested in vitro for activity against bloodstream forms of T."7.85Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine. ( Rushworth, SA; Steverding, D, 2017)
" For these reasons, the anti-glioblastoma drug temozolomide was tested in vitro for activity against bloodstream forms of T."3.85Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine. ( Rushworth, SA; Steverding, D, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steverding, D1
Rushworth, SA1

Other Studies

1 other study available for temozolomide and Trypanosomiasis, African

ArticleYear
Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
    Experimental parasitology, 2017, Volume: 178

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Eflornit

2017